Licence to Compound or Dispense Medicines: Application fee : Notice No. 758 of 2003
Form: Application for a Licence to Compound or Dispense Medicines : Notice No. 759 of 2003
Fees Payable in terms of the Provisions of the Medicines and Related Substances Act, 1965 : Notice No. 784 of 2015
Registration of Oral Preparations containing Bacterial Strains : Notice No. 1256 of 2017
Annual Single Exit Price Adjustment [SEPA] of Medicines and Scheduled Substances for the year 2019 : Notice No. 29 of 2019
Exemption of Medical Devices and In-Vitro Diagnostics (IVDS) from the Provisions of Section 18A and 18B of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965), as Amended : Notice No. R.685 of 2019
[Repealed] Fees Payable in terms of the Provisions of the Medicines and Related Substances Act, 1965 : Notice No. 695 of 2019
Exemption of Medical Devices and In-Vitro Diagnostics (IVDS) from the Provisions of Sections 18A and 18B of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965), as Amended : Notice No. 696 of 2019
Exclusion of Schedules 2, 3 and 4 substances from the operation of certain provisions of the Act : Notice No. R. 481 of 2020
Exclusion of Schedules 2, 3 and 4 substances from the requirement in Section 22A(6)(f) of the Act : Notice No. 514 of 2020
Exclusion of Medicines, Medical Devices and In Vitro Diagnostics (IVDs) donated to the State from the Operation of certain provisions of the Act : Notice No. R. 585 of 2020
Exclusion of certain alcohol-based hand-rubs from the operation of specified provisions of the Act : Notice No. R. 721 of 2020
Notification of Retention Fee Payment : Notice No. R. 164 of 2021
Exclusion of Schedule 2, 3 and 4 substances from the operation of certain provisions of the Act : Notice No. 252 of 2021
Exclusion of certain alcohol-based hand-rubs from the operation of specified provisions of the Act : Notice No. R. 756 of 2021
Exclusion of COVID-19 Vaccines from the Operation of Certain Provisions of the Act : Notice No. 1502 of 2021
Exclusion of Schedule 0 Medicines from the Operation of Sections 22G and 18A of the Act : Notice No. 1581 of 2021
Extension to the Exemption of Medical Devices and In-Vitro Diagnotistics (IVDs) from the Provisions of Section 18A and Section 18B of the Act: Notice No. R. 1632 of 2021
Annual Single Exit Price Adjustment [SEPA] of Medicines and Scheduled Substances for the year 2023 : Notice No. 2940 of 2023
Exclusion of certain alcohol-based hand-rubs from the operation of certain provisions of the Act : Notice No. 3382 of 2023
Exclusion of Schedule Zero (0) Medicines from the operations of Sections 22G and 18A of the Act : Notice No. 3800 of 2023
Second Single Exit Price Increase [SEPI] of Medicines and Scheduled Substances for the year 2023 [Top-up SEPI] : Notice No. 3801 of 2023
Exemption of Manufacturers, Wholesalers and Distributors of Class A Medical and In Vitro Diagnostics from the Operation of the provisions of Section 22C of the Act : Notice No. 4406 of 2024
Exclusion of Medicines from the application of certain provisions of Regulation 12 of the General Regulations made in terms of the Act : Notice No. 5361 of 2024
